Help for difficult-to-treat schizophrenia patients (IMAGE)
Caption
Michael Halassa, a Fralin Biomedical Research Insttute psychiatrist and neuroscientist, addresses scientists, clinicians and industry representatives during the Precision Therapeutics for Schizophrenia Symposium in Roanoke.
Credit
Stephanie Klein-Davis/Virginia Tech.
Usage Restrictions
For use with accompanying news
License
Original content